CHA Response to Drug Shortages White Paper

CHA Response to Drug Shortages White Paper

CHA submitted comments on a drug shortages white paper to highlight pediatric health care needs.
Download

Children’s Hospital Association submitted comments on a drug shortages white paper from Senate Finance Committee Chair Sen. Ron Wyden (D-Ore.) and Ranking Member Sen. Mike Crapo (R-Idaho).

Our comments highlight the need to ensure that hospital prevention and mitigation plans for drug shortages incorporate pediatric drug alternatives and safety considerations.

Related Content

Summary of Laboratory Developed Tests Final Rule

Children's Hospital Association sent a letter to Energy and Commerce leaders supporting pediatric-focused legislation included in a recent markup.

July 17, 2024

CHA Submits Energy and Commerce Committee Statement on Oversight of the 340B Drug Pricing Program

Children's Hospital Association urges the committee to work with provider stakeholders to enhance the effectiveness and integrity of the program for children's health.

July 09, 2024

Addressing Pediatric Drug and Supply Shortages

Children’s hospitals depend on a reliable and safe drug and supply chain to provide life-saving treatments to their pediatric patients.

June 11, 2024